NFE2L2 and Sjogren syndrome: Melatonin inhibits ferroptosis in salivary gland epithelial cells in primary Sjögren’s syndrome via the NRF2/HO-1/GPX4 signaling pathway, thereby attenuating ferroptosis-triggered NF-κB activation (35).